Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MAG is a gene implicated in neurodegeneration research. Key relationships include: activates, contributes to, inhibits. Associated with Als, Inflammation, Multiple Sclerosis. Connected to 21 entities in the SciDEX knowledge graph.
| Gene Symbol | MAG |
| Full Name | Myelin-Associated Glycoprotein |
| Chromosome | 19q13.12 |
| Protein Type | Type I membrane protein, Siglec family |
| Function | is a critical component of the myelin sheath in the central and peripheral nervous systems. |
| Pathways | Apoptosis, Oxidative Stress |
| UniProt ID | P20916 |
| NCBI Gene ID | 4099 |
| Ensembl ID | ENSG00000141670 |
| OMIM | 159460 |
| GeneCards | MAG |
| Human Protein Atlas | MAG |
| Associated Diseases | ALS, Alzheimer |
| Known Drugs/Compounds | aducanumab |
| Interactions | MIRO1, PLP1, MBP, GFAP, OLIG1, SIGLEC11 |
| KG Connections | 98 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
MAG["<b>MAG</b>"]
MIRO1["MIRO1"]
MAG -->|"inhibits"| MIRO1
AXONAL_MITOCHONDRIAL_TRANSPORT["AXONAL MITOCHONDRIAL TRANSPORT"]
MAG -->|"inhibits"| AXONAL_MITOCHONDRIAL_TRANSPORT
neurodegeneration["neurodegeneration"]
MAG -->|"implicated in"| neurodegeneration
CNTN6["CNTN6"]
CNTN6 -->|"upregulates"| MAG
HDAC6["HDAC6"]
HDAC6 -->|"inhibits"| MAG
RHOA["RHOA"]
RHOA -->|"activates"| MAG
style MAG fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| oligodendrocytes | expressed_in | cell_type | 0.70 |
| Als | contributes_to | disease | 0.65 |
| Multiple Sclerosis | contributes_to | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| MIRO1 | inhibits | gene | 0.60 |
| HK1 | regulates | gene | 0.60 |
| PLCB1 | regulates | gene | 0.60 |
| NDUFS7 | regulates | gene | 0.60 |
| CAPZB | regulates | gene | 0.60 |
| NDUFA4 | regulates | gene | 0.60 |
| PLP1 | inhibits | gene | 0.60 |
| MBP | inhibits | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| CD81 | regulates | gene | 0.60 |
| OLIG1 | inhibits | gene | 0.60 |
| Neural Progenitor | inhibits | cell_type | 0.60 |
| Hemoglobin | expressed_in | protein | 0.60 |
| MBP | associated_with | gene | 0.60 |
| MBP | biomarker_for | gene | 0.60 |
| SIGLEC11 | interacts_with | gene | 0.60 |
| schizophrenia | interacts_with | disease | 0.60 |
| neurodegeneration | interacts_with | disease | 0.60 |
| AXONAL MITOCHONDRIAL TRANSPORT | inhibits | gene | 0.60 |
| ATP | contributes_to | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| Oxidative Stress | activates | pathway | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| Oligodendrocyte | inhibits | cell_type | 0.60 |
| Neuron | inhibits | cell_type | 0.60 |
| Astrocyte | inhibits | cell_type | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| Amyloid | associated_with | pathway | 0.60 |
| Myelination | inhibits | pathway | 0.60 |
| Aβ | regulates | protein | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| Raf | regulates | protein | 0.60 |
| App | associated_with | protein | 0.60 |
| Ras | inhibits | protein | 0.60 |
| App | inhibits | protein | 0.60 |
| OLIGODENDROCYTE | associated_with | gene | 0.60 |
| Alzheimer's disease | interacts_with | disease | 0.60 |
| autism spectrum disorder | interacts_with | disease | 0.60 |
| Progenitor Cell | expressed_in | cell_type | 0.55 |
| Spinal Cord | expressed_in | brain_region | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CNTN6 | upregulates | gene | 0.70 |
| INFLAMMATION | activates | phenotype | 0.65 |
| HDAC6 | inhibits | gene | 0.60 |
| RHOA | activates | gene | 0.60 |
| MOG | activates | gene | 0.60 |
| MBP | activates | gene | 0.60 |
| CD81 | regulates | gene | 0.60 |
| GDI2 | regulates | gene | 0.60 |
| OLIG1 | inhibits | gene | 0.60 |
| HK1 | regulates | gene | 0.60 |
| CAPZB | regulates | gene | 0.60 |
| NDUFS7 | regulates | gene | 0.60 |
| NDUFA4 | regulates | gene | 0.60 |
| MBP | inhibits | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| PLCB1 | regulates | gene | 0.60 |
| PLP1 | inhibits | gene | 0.60 |
| aducanumab | targets | drug | 0.60 |
| APOE4 | associated_with | gene | 0.60 |
| GPR37 | interacts_with | gene | 0.60 |
| BIN1 | biomarker_for | gene | 0.60 |
| CD33 | interacts_with | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| INFLAMMATION | contributes_to | gene | 0.60 |
| MITOCHONDRIA | contributes_to | gene | 0.60 |
| OLIGODENDROCYTE | activates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| MYELIN | inhibits | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| ASTROCYTE | inhibits | gene | 0.60 |
| OLIGODENDROCYTE | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| GDI2 | co_expressed_with | gene | 0.50 |
| HK1 | co_expressed_with | gene | 0.50 |
| ADUCANUMAB | associated_with | drug | 0.45 |
| GFAP | co_discussed | gene | 0.40 |
| ASTROCYTE | co_discussed | cell_type | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa | 0.700 | - | Do β-amyloid plaques and neurofibrillary |
| PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Su | 0.562 | neurodegeneration | What upstream mechanisms trigger p53 act |
| Microglial TREM2 downregulation impairs damage-associated re | 0.507 | Alzheimer's disease | SEA-AD Single-Cell Analysis: Cell-Type V |
| TYRO3-STAT1 Axis to Preserve Parvalbumin Interneuron Functio | 0.499 | neuroinflammation | Why do TAM receptors protect against neu |
| Magnetosonic-Triggered Transferrin Receptor Clustering | 0.470 | neurodegeneration | Blood-brain barrier transport mechanisms |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.455
neurodegeneration | 2026-04-15 | 0 hypotheses
neurodegeneration | 2026-04-14 | 0 hypotheses
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.614
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] | Sehlin D, Hultqvist G, Michno W, Aguilar | J Prev Alzheimers Dis | 2025 | 1 |
| Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] | Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z | Exp Neurol | 2023 | 1 |
| On Iron Metabolism and Its Regulation. [PMID:33925597] | Vogt AS, Arsiwala T, Mohsen M, Vogel M, | Int J Mol Sci | 2021 | 1 |
| Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] | Feng H, Schorpp K, Jin J, Yozwiak CE, Ho | Cell Rep | 2020 | 1 |
| Transferrin and transferrin receptors update. [PMID:29969719] | Kawabata H | Free Radic Biol Med | 2019 | 1 |
| A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma. [PMID:41592623] | Chen S, Qi T, Peng H, Kimura E, Zhang X | J Control Release | 2026 | 0 |
| Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] | Lu Y, Zhang Y, Niu C | Comp Biochem Physiol A Mol Int | 2026 | 0 |
| Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] | Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam | J Trace Elem Med Biol | 2026 | 0 |
| Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] | Piotrowsky A, Leischner C, Schmieder H, | Oncol Rep | 2026 | 0 |
| Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance fo [PMID:41944296] | Gong W, Hui W, Qiao S, Ji Q, Liu M et al | Adv Sci (Weinh) | 2026 | 0 |
| Cerebrospinal Fluid from Restless Legs Syndrome Patients Reduces Iron Uptake in [PMID:41947413] | Palsa K, Sahu AP, Rye DB, Trotti LM, Elc | Ann Neurol | 2026 | 0 |
| Pulmonary neuroendocrine cell-derived exosomes regulate iron homeostasis and oxi [PMID:41950316] | Thakur A, Zhang K, Chen J, Mei S, Chen J | Sci Adv | 2026 | 0 |
| O-GlcNAc Modification Orchestrates HUWE1-Mediated Ubiquitination of TfR1 to Regu [PMID:41962599] | Zhang H, Li M, Zhang J, Sun Q, Jin X et | Free Radic Biol Med | 2026 | 0 |
| Protective Role of Polydatin Against Vancomycin-Induced Lung Toxicity via Oxidat [PMID:41963266] | Aygörmez S, Küçükler S, Çomaklı S, Şimşe | J Appl Toxicol | 2026 | 0 |
| Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] | Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng | American journal of translatio | 2026 | 0 |
| Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] | Zemmouche M, Falque G, Cadet F, Gardebie | Journal of molecular graphics | 2026 | 0 |
| [Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] | Wang YF, Dong YS | Zhen ci yan jiu = Acupuncture | 2026 | 0 |
| The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] | Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H | Apoptosis : an international j | 2026 | 0 |
| The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] | Osmanlioglu Dag SR, Tatli Cankaya II, Oz | Anti-cancer agents in medicina | 2026 | 0 |
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |